Notts - Muscle Aches and Pain

Description

NOTTS™ 8HR* is formulated to provide relief from muscle aches and pain, specifically targeting minor muscle discomfort. Each caplet contains 650 mg of acetaminophen, a recognized fever reducer. The product is packaged in a bottle containing 24 caplets. The National Drug Code (NDC) for NOTTS™ 8HR* is 82706-008-01.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including common cold, headache, toothache, muscular aches, backaches, premenstrual and menstrual cramps, and minor pain from arthritis. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and over are advised to take 1 caplet every 4 to 6 hours as needed. The maximum dosage should not exceed 6 caplets within a 24-hour period, unless otherwise directed by a healthcare professional. Additionally, this medication should not be used for more than 10 consecutive days unless specifically instructed by a doctor.

For children under 12 years of age, it is recommended to consult a healthcare professional for appropriate dosing guidance.

Contraindications

Use of this product is contraindicated in the following situations:

• Co-administration with any other drug containing acetaminophen, whether prescription or nonprescription, is prohibited. If there is uncertainty regarding the presence of acetaminophen in another medication, consultation with a healthcare professional is advised.

• This product should not be used in individuals with a known allergy to acetaminophen or any of its inactive ingredients.

Warnings and Precautions

This product contains acetaminophen, which can lead to severe damage if the following guidelines are not adhered to: do not exceed 4,000 mg of acetaminophen within a 24-hour period, as this is the maximum daily dosage. Additionally, caution is advised against the concurrent use of other medications containing acetaminophen and the consumption of three or more alcoholic drinks daily while using this product.

Acetaminophen has the potential to cause severe skin reactions. Symptoms indicative of such reactions may include skin reddening, rash, and blisters. Should any of these symptoms manifest, it is imperative to discontinue use immediately and seek medical attention.

General precautions should be observed prior to use. Individuals with liver disease should consult a healthcare professional before using this product. Furthermore, those taking the anticoagulant warfarin should seek advice from a doctor or pharmacist before use.

In the event of an overdose, it is crucial to obtain emergency medical assistance or contact a Poison Control Center without delay. Prompt medical attention is essential for both adults and children, even if no signs or symptoms are initially apparent.

Users should also discontinue use and consult a healthcare provider if any of the following occur: pain persists for more than 10 days, pain lasts more than 3 days, pain or fever worsens, new symptoms arise, or if redness or swelling is observed. These symptoms may indicate a serious underlying condition that requires medical evaluation.

Side Effects

Patients using this product should be aware of potential adverse reactions associated with acetaminophen.

Severe liver damage may occur if patients exceed 4,000 mg of acetaminophen in a 24-hour period, which is the maximum recommended daily amount. Additionally, the risk of liver damage increases when acetaminophen is taken in conjunction with other medications containing acetaminophen or when consumed with three or more alcoholic drinks daily.

Patients should also be alert for severe skin reactions, which may manifest as skin reddening, rash, or blisters. If any of these symptoms occur, patients are advised to discontinue use immediately and seek medical attention.

It is contraindicated to use this product with any other drug containing acetaminophen, whether prescription or nonprescription. Patients who are allergic to acetaminophen or any of the inactive ingredients should not use this product.

Before using this product, patients with liver disease should consult a healthcare professional. Furthermore, individuals taking the blood-thinning medication warfarin should seek advice from a doctor or pharmacist prior to use.

Patients are instructed to stop using the product and consult a healthcare provider if pain persists for more than 10 days, if pain lasts more than 3 days, if pain or fever worsens, if new symptoms arise, or if redness or swelling is observed, as these may indicate a serious condition.

In the event of an overdose, it is critical for patients to seek medical help or contact a Poison Control Center immediately, as prompt medical attention is essential for both adults and children, even if no signs or symptoms are present.

Drug Interactions

Patients taking the anticoagulant warfarin should consult a healthcare professional prior to initiating treatment with this medication. The interaction between this drug and warfarin may necessitate careful monitoring of coagulation parameters to ensure therapeutic efficacy and minimize the risk of adverse effects. Adjustments to the dosage of warfarin may be required based on the clinical judgment of the healthcare provider.

Packaging & NDC

Below are the non-prescription pack sizes of Notts - Muscle Aches and Pain (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended dosage is 1 caplet every 4 to 6 hours, with a maximum of 6 caplets in a 24-hour period, unless otherwise directed by a physician. The use of this medication should not exceed 10 days unless specifically instructed by a healthcare provider.

In cases of overdose, it is essential to seek prompt medical attention for both adults and pediatric patients, even if no signs or symptoms are immediately apparent.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment should exercise caution when using this product, which contains acetaminophen. It is critical to adhere to the maximum daily dosage of 4,000 mg of acetaminophen, as exceeding this limit may result in severe liver damage. Additionally, patients should avoid concomitant use with other medications containing acetaminophen to prevent unintentional overdose.

Patients with compromised liver function are advised to consult a healthcare professional prior to using this product, particularly if they have a history of liver disease. Furthermore, it is recommended that patients limit alcohol consumption to fewer than three alcoholic drinks per day while using this product, as increased alcohol intake may exacerbate the risk of liver damage. Regular monitoring of liver function may be warranted in patients with existing hepatic impairment to ensure safety and efficacy during treatment.

Overdosage

In the event of an overdose, it is imperative that the recommended dosage is not exceeded. Should an overdose occur, immediate medical assistance must be sought, or the individual should contact a Poison Control Center without delay.

Prompt medical attention is crucial for both adults and children, even in the absence of noticeable signs or symptoms. Healthcare professionals are advised to monitor the patient closely and initiate appropriate management procedures as necessary.

Nonclinical Toxicology

There is currently no available information regarding teratogenic effects. Additionally, no data has been provided concerning non-teratogenic effects. The nonclinical toxicology section does not contain any relevant information at this time. Furthermore, there is no information available related to animal pharmacology and toxicology.

Postmarketing Experience

Postmarketing experience has identified that acetaminophen may be associated with severe skin reactions. Reported symptoms of these reactions include skin reddening, rash, and blisters. In the event of a skin reaction, it is advised to discontinue use of the medication and seek medical attention immediately.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. Patients should be informed not to use this medication in conjunction with any other drug that contains acetaminophen, whether prescription or nonprescription. If patients are uncertain about whether a drug contains acetaminophen, they should be encouraged to consult with a doctor or pharmacist.

It is crucial to inform patients not to use this medication if they have a known allergy to acetaminophen or any of the inactive ingredients. Patients should be instructed to stop using the medication and seek medical advice if their pain persists for more than 10 days or if it lasts more than 3 days without improvement. Additionally, they should be advised to contact a doctor if their pain or fever worsens, if new symptoms arise, or if they notice any redness or swelling, as these may indicate a serious condition.

Patients with liver disease should be encouraged to consult a doctor before using this medication. Furthermore, those taking the blood-thinning medication warfarin should be advised to speak with a doctor or pharmacist prior to use to ensure safety and avoid potential interactions.

Storage and Handling

The product is supplied in a tamper-evident carton. It is essential to inspect the packaging prior to use; do not utilize the product if the carton is open or if the foil inner seal is broken or missing.

For optimal storage, the product should be maintained at a temperature range of 20-25°C (68-77°F). Proper adherence to these storage conditions is crucial to ensure the integrity and efficacy of the product.

Additional Clinical Information

The medication is administered orally. For adults and children aged 12 years and older, the recommended dosage is one caplet every 4 to 6 hours, with a maximum of six caplets in a 24-hour period, unless otherwise directed by a physician. It is advised not to use the medication for more than 10 days without medical guidance. For children under 12 years, consultation with a doctor is recommended prior to use.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Notts - Muscle Aches and Pain, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)